{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:17:28Z","timestamp":1790299048499,"version":"4.1.0"},"reference-count":343,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Almost 25% of schizophrenia patients suffer from obsessive-compulsive symptoms (OCS) considered a transdiagnostic clinical continuum. The presence of symptoms pertaining to both schizophrenia and obsessive-compulsive disorder (OCD) may complicate pharmacological treatment and could contribute to lack or poor response to the therapy. Despite the clinical relevance, no reviews have been recently published on the possible neurobiological underpinnings of this comorbidity, which is still unclear. An integrative view exploring this topic should take into account the following aspects: (i) the implication for glutamate, dopamine, and serotonin neurotransmission as demonstrated by genetic findings; (ii) the growing neuroimaging evidence of the common brain regions and dysfunctional circuits involved in both diseases; (iii) the pharmacological modulation of dopaminergic, serotoninergic, and glutamatergic systems as current therapeutic strategies in schizophrenia OCS; (iv) the recent discovery of midbrain dopamine neurons and dopamine D1- and D2-like receptors as orchestrating hubs in repetitive and psychotic behaviors; (v) the contribution of N-methyl-D-aspartate receptor subunits to both psychosis and OCD neurobiology. Finally, we discuss the potential role of the postsynaptic density as a structural and functional hub for multiple molecular signaling both in schizophrenia and OCD pathophysiology.<\/jats:p>","DOI":"10.3390\/biom13081220","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T10:21:39Z","timestamp":1691230899000},"page":"1220","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia"],"prefix":"10.3390","volume":"13","author":[{"given":"Licia","family":"Vellucci","sequence":"first","affiliation":[{"name":"Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Dentistry University Medical School of Naples \u201cFederico II\u201d, Via Pansini 5, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8944-414X","authenticated-orcid":false,"given":"Mariateresa","family":"Ciccarelli","sequence":"additional","affiliation":[{"name":"Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Dentistry University Medical School of Naples \u201cFederico II\u201d, Via Pansini 5, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta Filomena","family":"Buonaguro","sequence":"additional","affiliation":[{"name":"Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Dentistry University Medical School of Naples \u201cFederico II\u201d, Via Pansini 5, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-0853","authenticated-orcid":false,"given":"Michele","family":"Fornaro","sequence":"additional","affiliation":[{"name":"Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Dentistry University Medical School of Naples \u201cFederico II\u201d, Via Pansini 5, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5156-658X","authenticated-orcid":false,"given":"Giordano","family":"D\u2019Urso","sequence":"additional","affiliation":[{"name":"Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Dentistry University Medical School of Naples \u201cFederico II\u201d, Via Pansini 5, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0422-3415","authenticated-orcid":false,"given":"Giuseppe","family":"De Simone","sequence":"additional","affiliation":[{"name":"Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Dentistry University Medical School of Naples \u201cFederico II\u201d, Via Pansini 5, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Iasevoli","sequence":"additional","affiliation":[{"name":"Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Dentistry University Medical School of Naples \u201cFederico II\u201d, Via Pansini 5, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2751-5683","authenticated-orcid":false,"given":"Annarita","family":"Barone","sequence":"additional","affiliation":[{"name":"Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Dentistry University Medical School of Naples \u201cFederico II\u201d, Via Pansini 5, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"de Bartolomeis","sequence":"additional","affiliation":[{"name":"Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Dentistry University Medical School of Naples \u201cFederico II\u201d, Via Pansini 5, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jpsychires.2004.09.004","article-title":"Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: Diagnostic dilemmas and therapeutic implications","volume":"39","author":"Poyurovsky","year":"2005","journal-title":"J. Psychiatr. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00023210-200418140-00004","article-title":"Obsessive-compulsive disorder in schizophrenia: Clinical characteristics and treatment","volume":"18","author":"Poyurovsky","year":"2004","journal-title":"CNS Drugs"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/schbul\/sbp148","article-title":"How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association","volume":"37","author":"Achim","year":"2011","journal-title":"Schizophr. Bull."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/15622975.2011.559271","article-title":"Obsessive-compulsive symptoms in schizophrenia: Prevalence, clinical features and treatment. A literature review","volume":"13","author":"Hadi","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_5","first-page":"345","article-title":"Frequency and severity of obsessive-compulsive symptoms\/disorders, violence and suicidal in schizophrenic patients","volume":"14","author":"Hosseini","year":"2012","journal-title":"Iran. Red Crescent Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2018.05.029","article-title":"Comparison of neurocognitive domains in patients with schizophrenia with and without co-morbid obsessive compulsive disorder","volume":"201","author":"Sahoo","year":"2018","journal-title":"Schizophr. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2019.05.024","article-title":"Risk of schizophrenia among people with obsessive-compulsive disorder: A nationwide population-based cohort study","volume":"209","author":"Cheng","year":"2019","journal-title":"Schizophr. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pnpbp.2015.08.010","article-title":"Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones","volume":"65","author":"Iasevoli","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/YCO.0000000000000853","article-title":"Obsessive-compulsive symptoms in the schizophrenia-spectrum: Current developments in psychopathology research","volume":"36","author":"Rasmussen","year":"2023","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"317980","DOI":"10.1155\/2014\/317980","article-title":"Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment","volume":"2014","author":"Zink","year":"2014","journal-title":"Adv. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia\u2014The role of clozapine","volume":"14","author":"Meltzer","year":"1997","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4088\/JCP.18com12123","article-title":"Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia","volume":"80","author":"Kane","year":"2019","journal-title":"J. Clin. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.psc.2016.01.006","article-title":"Treatment-Resistant Schizophrenia","volume":"39","author":"Elkis","year":"2016","journal-title":"Psychiatr. Clin. N. Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"ref_16","first-page":"15","article-title":"Obsessive-compulsive disorder in schizophrenia: Epidemiologic and biologic overlap","volume":"24","author":"Tibbo","year":"1999","journal-title":"J. Psychiatry Neurosci. JPN"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2207545119","DOI":"10.1073\/pnas.2207545119","article-title":"Midbrain dopamine neurons arbiter OCD-like behavior","volume":"119","author":"Xue","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/YCO.0000000000000017","article-title":"Obsessive compulsive disorder and the glutamatergic system","volume":"27","author":"Stein","year":"2014","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ajmg.b.32137","article-title":"Meta-analysis of association between obsessive-compulsive disorder and the 3\u2032 region of neuronal glutamate transporter gene SLC1A1","volume":"162b","author":"Stewart","year":"2013","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/da.22896","article-title":"Hoarding: A meta-analysis of age of onset","volume":"36","author":"Zaboski","year":"2019","journal-title":"Depress. Anxiety"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fphar.2013.00099","article-title":"Comorbid obsessive-compulsive symptoms in schizophrenia: Contributions of pharmacological and genetic factors","volume":"4","author":"Schirmbeck","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1440-1819.2007.01685.x","article-title":"Early prodromal symptoms and diagnoses before first psychotic episode in 219 inpatients with schizophrenia","volume":"61","author":"Shioiri","year":"2007","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.schres.2008.11.023","article-title":"Obsessive compulsive symptoms in the psychosis prodrome: Correlates of clinical and functional outcome","volume":"108","author":"Niendam","year":"2009","journal-title":"Schizophr. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/schbul\/sbr077","article-title":"The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders","volume":"39","author":"Sterk","year":"2013","journal-title":"Schizophr. Bull."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11920-014-0510-8","article-title":"Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: A review of the experimental literature","volume":"16","author":"Fonseka","year":"2014","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.comppsych.2009.10.007","article-title":"Do the obsessive-compulsive symptoms have an effect in schizophrenia?","volume":"51","author":"Tiryaki","year":"2010","journal-title":"Compr. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/WNF.0b013e318184fafd","article-title":"The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia","volume":"32","author":"Kim","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/13651501.2014.943243","article-title":"Obsessive compulsive symptoms are related to lower quality of life in patients with Schizophrenia","volume":"18","year":"2014","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.comppsych.2014.09.015","article-title":"Prevalence and clinical correlates of obsessive-compulsive disorder in schizophrenia","volume":"56","author":"Devi","year":"2015","journal-title":"Compr. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.psychres.2013.05.029","article-title":"The effect of obsessive-compulsive symptomatology on executive functions in schizophrenia: A systematic review and meta-analysis","volume":"210","author":"Cunill","year":"2013","journal-title":"Psychiatry Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamapsychiatry.2014.1011","article-title":"Obsessive-compulsive disorder as a risk factor for schizophrenia: A nationwide study","volume":"71","author":"Meier","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000098490","article-title":"Obsession in the strict sense: A helpful psychopathological phenomenon in the differential diagnosis between obsessive-compulsive disorder and schizophrenia","volume":"40","year":"2007","journal-title":"Psychopathology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.psychres.2007.02.019","article-title":"Clinical characteristics of schizotypal-related obsessive-compulsive disorder","volume":"159","author":"Poyurovsky","year":"2008","journal-title":"Psychiatry Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1176\/jnp.12.1.91","article-title":"Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: A pilot study","volume":"12","author":"Hwang","year":"2000","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_35","first-page":"187","article-title":"Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of schizophrenia?","volume":"30","author":"Bottas","year":"2005","journal-title":"J. Psychiatry Neurosci. JPN"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/jnp.13.1.115","article-title":"Obsessive-compulsive schizophrenia: A new diagnostic entity?","volume":"13","author":"Reznik","year":"2001","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1176\/jnp.17.2.254","article-title":"Obsessive and compulsive symptoms in schizophrenia patients--from neuropsychology to clinical typology and classification","volume":"17","author":"Reznik","year":"2005","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.comppsych.2011.08.009","article-title":"Obsessive-compulsive symptoms in schizophrenia: Implications for future psychiatric classifications","volume":"53","author":"Poyurovsky","year":"2012","journal-title":"Compr. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5498\/wjp.v3.i3.50","article-title":"Differential diagnosis of obsessive-compulsive symptoms from delusions in schizophrenia: A phenomenological approach","volume":"3","author":"Oulis","year":"2013","journal-title":"World J. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archgenpsychiatry.2009.155","article-title":"Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms","volume":"66","author":"Kwon","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ajmg.b.31242","article-title":"Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive-compulsive symptoms","volume":"156b","author":"Ryu","year":"2011","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature06104","article-title":"Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice","volume":"448","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.2125","article-title":"Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice","volume":"16","author":"Shmelkov","year":"2010","journal-title":"Nat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1073\/pnas.94.9.4572","article-title":"Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder","volume":"94","author":"Karayiorgou","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/schbul\/sbm019","article-title":"Is COMT a susceptibility gene for schizophrenia?","volume":"33","author":"Williams","year":"2007","journal-title":"Schizophr. Bull."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neubiorev.2017.05.029","article-title":"A review of the role of serotonin system genes in obsessive-compulsive disorder","volume":"80","author":"Sinopoli","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jad.2016.10.020","article-title":"The serotonin transporter gene 5-HTTLPR polymorphism is associated with affective psychoses but not with schizophrenia: A large-scale study in the Russian population","volume":"208","author":"Golimbet","year":"2017","journal-title":"J. Affect. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pnpbp.2008.11.013","article-title":"No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients","volume":"33","author":"Lee","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_49","first-page":"453","article-title":"Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia","volume":"11","author":"Kastelic","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1017\/neu.2013.22","article-title":"Association of schizophrenia with T102C (rs6313) and 1438 A\/G (rs6311) polymorphisms of HTR2A gene","volume":"25","author":"Yildiz","year":"2013","journal-title":"Acta Neuropsychiatr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/mp.2009.100","article-title":"Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study","volume":"16","author":"Voyiaziakis","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/503850","article-title":"Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder","volume":"78","author":"Hu","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2014.09.014","article-title":"Specific and common genes implicated across major mental disorders: A review of meta-analysis studies","volume":"60","author":"Gatt","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41537-023-00348-x","article-title":"Shared genetic loci and causal relations between schizophrenia and obsessive-compulsive disorder","volume":"9","author":"Chen","year":"2023","journal-title":"Schizophrenia"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2010.06.002","article-title":"Genetic associations of brain structural networks in schizophrenia: A preliminary study","volume":"68","author":"Jagannathan","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/NDT.S190563","article-title":"Association between the SLC6A4 gene and schizophrenia: An updated meta-analysis","volume":"15","author":"Xu","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","article-title":"Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective","volume":"15","author":"Pauls","year":"2014","journal-title":"Nat. Reviews. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00213-013-3137-2","article-title":"Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms","volume":"230","author":"Cai","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0253-7176.53308","article-title":"Neuroanatomical, neurochemical, and neurodevelopmental basis of obsessive-compulsive symptoms in schizophrenia","volume":"31","author":"Venkatasubramanian","year":"2009","journal-title":"Indian J. Psychol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1176\/appi.ajp.160.12.2209","article-title":"Complexity of prefrontal cortical dysfunction in schizophrenia: More than up or down","volume":"160","author":"Callicott","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eurpsy.2013.02.004","article-title":"Working memory dysfunction in schizophrenia patients with obsessive-compulsive symptoms: An fMRI study","volume":"29","author":"Hendler","year":"2014","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"ref_62","first-page":"560","article-title":"Does co-morbid obsessive-compulsive disorder modify the abnormal language processing in schizophrenia patients? An FMRI study","volume":"8","author":"Poyurovsky","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Yu, X.M., Qiu, L.L., Huang, H.X., Zuo, X., Zhou, Z.H., Wang, S., Liu, H.S., and Tian, L. (2021). Comparison of resting-state spontaneous brain activity between treatment-naive schizophrenia and obsessive-compulsive disorder. BMC Psychiatry, 21.","DOI":"10.1186\/s12888-021-03554-y"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpsychires.2021.12.042","article-title":"Transdiagnostic role of glutamate and white matter damage in neuropsychiatric disorders: A Systematic Review","volume":"147","author":"Luttenbacher","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","article-title":"Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine","volume":"39","author":"Rosenberg","year":"2000","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/CHI.0b013e318185d2be","article-title":"Brain imaging in pediatric obsessive-compulsive disorder","volume":"47","author":"MacMaster","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biopsych.2012.06.023","article-title":"A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder","volume":"73","author":"Brennan","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pscychresns.2006.02.003","article-title":"Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients","volume":"154","author":"Sumitani","year":"2007","journal-title":"Psychiatry Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.64.8.946","article-title":"Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder","volume":"64","author":"Harrison","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3956(00)00022-4","article-title":"fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder","volume":"34","author":"Adler","year":"2000","journal-title":"J. Psychiatr. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1176\/ajp.155.11.1584","article-title":"A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects","volume":"155","author":"Bartha","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.61.7.720","article-title":"Mapping structural brain alterations in obsessive-compulsive disorder","volume":"61","author":"Pujol","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder","volume":"42","author":"Perani","year":"2008","journal-title":"NeuroImage"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1503\/jpn.140021","article-title":"Increased orbitofrontal cortex activation associated with \u201cpro-obsessive\u201d antipsychotic treatment in patients with schizophrenia","volume":"40","author":"Schirmbeck","year":"2015","journal-title":"J. Psychiatry Neurosci. JPN"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0920-9964(97)00082-0","article-title":"Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia","volume":"27","author":"Deicken","year":"1997","journal-title":"Schizophr. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"ref_77","first-page":"956","article-title":"Functional Connectivity of the Striatum in Schizophrenia and Psychotic Bipolar Disorder","volume":"4","author":"Karcher","year":"2019","journal-title":"Biol. Psychiatry. Cogn. Neurosci. Neuroimaging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pscychresns.2009.02.005","article-title":"Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder","volume":"172","author":"Arnold","year":"2009","journal-title":"Psychiatry Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/00048670802050546","article-title":"Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder","volume":"42","author":"Wood","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/01.chi.0000132812.44664.2d","article-title":"Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls","volume":"43","author":"Rosenberg","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/01.jcp.0000144889.51072.03","article-title":"The advantages of choosing antiobsessive therapy according to decision-making functioning","volume":"24","author":"Cavedini","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_82","first-page":"11","article-title":"The role of dopamine in obsessive-compulsive disorder: Preclinical and clinical evidence","volume":"65","author":"Denys","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.biopsych.2004.01.023","article-title":"Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder","volume":"55","author":"Denys","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"681701","DOI":"10.3389\/fpsyt.2021.681701","article-title":"Altered Resting-State Brain Activity in Schizophrenia and Obsessive-Compulsive Disorder Compared With Non-psychiatric Controls: Commonalities and Distinctions Across Disorders","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_85","first-page":"442","article-title":"Identifying Schizo-Obsessive Comorbidity by Tract-Based Spatial Statistics and Probabilistic Tractography","volume":"46","author":"Wang","year":"2020","journal-title":"Schizophr. Bull."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/S1121189X00007934","article-title":"Developmental biomarkers in schizophrenia and other psychiatric disorders: Common origins, different trajectories?","volume":"14","author":"Keshavan","year":"2005","journal-title":"Epidemiol. E Psichiatr. Soc."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s12035-013-8534-3","article-title":"Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: Relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches","volume":"49","author":"Latte","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1517\/17460441.2013.845553","article-title":"Glutamate drugs and pharmacogenetics of OCD: A pathway-based exploratory approach","volume":"8","author":"Grados","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_89","first-page":"193","article-title":"Neuropsychological evaluation of adults with Down\u2019s syndrome: Patterns of selective impairment in non-demented old adults","volume":"33","author":"Haxby","year":"1989","journal-title":"J. Ment. Defic. Res."},{"key":"ref_90","first-page":"55","article-title":"Quetiapine and obsessive-compulsive symptoms (OCS): Case report and review of atypical antipsychotic-induced OCS","volume":"26","author":"Khullar","year":"2001","journal-title":"J. Psychiatry Neurosci. JPN"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0278-5846(03)00039-3","article-title":"Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases","volume":"27","author":"Lykouras","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.ftd.0000211801.66569.80","article-title":"Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive\/compulsive symptoms","volume":"28","author":"Lin","year":"2006","journal-title":"Ther. Drug Monit."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4088\/JCP.11m07164","article-title":"Obsessive-compulsive symptoms in patients with schizophrenia: A naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients","volume":"73","author":"Swets","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/WNF.0b013e31823429bd","article-title":"Aripiprazole improves olanzapine-associated obsessive compulsive symptoms in schizophrenia","volume":"34","author":"Schirmbeck","year":"2011","journal-title":"Clin. Neuropharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1017\/S0033291711000419","article-title":"Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia","volume":"41","author":"Schirmbeck","year":"2011","journal-title":"Psychol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/157015912799362724","article-title":"Clozapine-induced obsessive-compulsive symptoms in schizophrenia: A critical review","volume":"10","author":"Schirmbeck","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.comppsych.2008.11.005","article-title":"Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol","volume":"50","author":"Sa","year":"2009","journal-title":"Compr. Psychiatry"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.pnpbp.2010.08.021","article-title":"Obsessive compulsive disorder and symptoms may have different effects on schizophrenia","volume":"35","author":"Ceylan","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1017\/S003329171800017X","article-title":"Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia","volume":"48","author":"Worbe","year":"2018","journal-title":"Psychol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40501-016-0085-6","article-title":"Schizo-Obsessive Disorder: The Epidemiology, Diagnosis, and Treatment of Comorbid Schizophrenia and OCD","volume":"3","author":"Zhou","year":"2016","journal-title":"Curr. Treat. Options Psychiatry"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0269881112463470","article-title":"Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: A longitudinal study","volume":"27","author":"Schirmbeck","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1017\/S003329172100492X","article-title":"Clozapine-related obsessive-compulsive symptoms and their impact on wellbeing: A naturalistic longitudinal study","volume":"53","author":"Parkin","year":"2022","journal-title":"Psychol. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/WNF.0b013e31819cc8e6","article-title":"Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole","volume":"32","author":"Englisch","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000505876","article-title":"Clozapine-Associated Obsessive-Compulsive Symptoms and Their Management: A Systematic Review and Analysis of 107 Reported Cases","volume":"89","author":"Kim","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/YIC.0b013e32835bd24e","article-title":"Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: An open-label, prospective study","volume":"28","author":"Stryjer","year":"2013","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000012321","article-title":"Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine","volume":"68","author":"Biondi","year":"1999","journal-title":"Psychother. Psychosom."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00002826-199619040-00003","article-title":"Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients","volume":"19","author":"Poyurovsky","year":"1996","journal-title":"Clin. Neuropharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1176\/ajp.153.12.1625","article-title":"Fluoxetine augmentation of clozapine treatment in patients with schizophrenia","volume":"153","author":"Buchanan","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1176\/ajp.150.7.1127","article-title":"Treatment of schizophrenia with obsessive-compulsive features with serotonin reuptake inhibitors","volume":"150","author":"Hwang","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00004850-199903000-00006","article-title":"Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: An add-on open study","volume":"14","author":"Poyurovsky","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0034-1374611","article-title":"Clozapine-associated development of second-onset obsessive compulsive symptoms in schizophrenia: Impact of clozapine serum levels and fluvoxamine add-on","volume":"47","author":"Gahr","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e1362","DOI":"10.4088\/JCP.12f08200","article-title":"Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia","volume":"73","author":"Andrade","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-1781(92)90037-4","article-title":"Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder","volume":"42","author":"Marazziti","year":"1992","journal-title":"Psychiatry Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.mp.4001823","article-title":"A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder","volume":"11","author":"Bloch","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/0269881108099215","article-title":"Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms","volume":"24","author":"Poyurovsky","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.euroneuro.2014.06.014","article-title":"Treatment with Ziprasidone for schizophrenia patients with OCD","volume":"24","author":"Fostick","year":"2014","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2045125312467347","article-title":"Ziprasidone for obsessive compulsive disorder in schizophrenia","volume":"3","author":"Krause","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/JCP.0b013e318172755a","article-title":"Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: An open-label switch study","volume":"28","author":"Kim","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.4088\/JCP.v69n1202","article-title":"Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: An open-label study of 15 patients","volume":"69","author":"Glick","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.pnpbp.2009.06.014","article-title":"Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: A case report","volume":"33","author":"Angelucci","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_121","first-page":"34","article-title":"Schizophrenia with obsessive compulsive features","volume":"3","author":"Hwang","year":"2006","journal-title":"Psychiatry"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/psychiatry.IndianJPsychiatry_268_19","article-title":"Clinical correlates of obsessive-compulsive disorder comorbidity in patients with schizophrenia","volume":"62","author":"Kokurcan","year":"2020","journal-title":"Indian J. Psychiatry"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4088\/JCP.v63n1214b","article-title":"Behavior therapy attenuates clozapine-induced obsessions and compulsions","volume":"63","author":"MacCabe","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2005.04.043","article-title":"Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial","volume":"58","author":"Coric","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157488907779561727","article-title":"Glutamatergic dysfunction--newer targets for anti-obsessional drugs","volume":"2","author":"Bhattacharyya","year":"2007","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622975.2016.1190867","article-title":"Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition","volume":"18","author":"Bandelow","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajmg.b.32407","article-title":"Disorder-specific genetic factors in obsessive-compulsive disorder: A comprehensive meta-analysis","volume":"171b","author":"Taylor","year":"2016","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S0033291715001865","article-title":"Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study","volume":"46","author":"Kim","year":"2016","journal-title":"Psychol. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1515\/REVNEURO.2010.21.2.119","article-title":"Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies","volume":"21","author":"Nikolaus","year":"2010","journal-title":"Rev. Neurosci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn.2015.8","article-title":"Neurobiology of rodent self-grooming and its value for translational neuroscience","volume":"17","author":"Kalueff","year":"2016","journal-title":"Nat. Reviews. Neurosci."},{"key":"ref_131","first-page":"36","article-title":"Beyond the serotonin hypothesis: A role for dopamine in some forms of obsessive compulsive disorder?","volume":"51","author":"Goodman","year":"1990","journal-title":"J. Clin. Psychiatry"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Ollmann, T., L\u00e9n\u00e1rd, L., P\u00e9czely, L., Berta, B., Kertes, E., Zagor\u00e1cz, O., Hormay, E., L\u00e1szl\u00f3, K., Szab\u00f3, \u00c1., and G\u00e1losi, R. (2022). Effect of D1- and D2-like Dopamine Receptor Antagonists on the Rewarding and Anxiolytic Effects of Neurotensin in the Ventral Pallidum. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092104"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Martinotti, G., Chiappini, S., Pettorruso, M., Mosca, A., Miuli, A., Di Carlo, F., D\u2019Andrea, G., Collevecchio, R., Di Muzio, I., and Sensi, S.L. (2021). Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature. Brain Sci., 11.","DOI":"10.3390\/brainsci11070856"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1523\/JNEUROSCI.23-04-01198.2003","article-title":"Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia","volume":"23","author":"Martin","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pscychresns.2010.04.004","article-title":"Dopamine D(1) receptor binding in the anterior cingulate cortex of patients with obsessive-compulsive disorder","volume":"183","author":"Olver","year":"2010","journal-title":"Psychiatry Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/npp.2009.77","article-title":"Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder","volume":"34","author":"Bhattacharyya","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/mp.2017.154","article-title":"Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis","volume":"23","author":"Collaborative","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Poltavskaya, E.G., Fedorenko, O.Y., Kornetova, E.G., Loonen, A.J.M., Kornetov, A.N., Bokhan, N.A., and Ivanova, S.A. (2021). Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms. Life, 11.","DOI":"10.3390\/life11100997"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.psychres.2012.08.014","article-title":"Genetic analysis of the DLGAP1 gene as a candidate gene for schizophrenia","volume":"205","author":"Li","year":"2013","journal-title":"Psychiatry Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0304-3940(80)90178-0","article-title":"Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia","volume":"20","author":"Kim","year":"1980","journal-title":"Neurosci. Lett."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb05178.x","article-title":"Studies of amphetamine or methamphetamine psychosis in Japan: Relation of methamphetamine psychosis to schizophrenia","volume":"914","author":"Yui","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-0173(99)00046-6","article-title":"Serotonin model of schizophrenia: Emerging role of glutamate mechanisms","volume":"31","author":"Aghajanian","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.153.4.466","article-title":"Serotonin-dopamine interaction and its relevance to schizophrenia","volume":"153","author":"Kapur","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"de Bartolomeis, A., Ciccarelli, M., De Simone, G., Mazza, B., Barone, A., and Vellucci, L. (2023). Canonical and Non-Canonical Antipsychotics\u2019 Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia. Int. J. Mol. Sci., 24.","DOI":"10.37766\/inplasy2023.1.0079"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S1092852900021015","article-title":"Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia","volume":"12","author":"Stahl","year":"2007","journal-title":"CNS Spectr."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-012-2921-8","article-title":"Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: From receptor heterodimers to postsynaptic scaffolding and effector proteins","volume":"225","author":"Buonaguro","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"de Bartolomeis, A., De Simone, G., Ciccarelli, M., Castiello, A., Mazza, B., Vellucci, L., and Barone, A. (2022). Antipsychotics-Induced Changes in Synaptic Architecture and Functional Connectivity: Translational Implications for Treatment Response and Resistance. Biomedicines, 10.","DOI":"10.37766\/inplasy2022.11.0107"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1073\/pnas.90.20.9576","article-title":"Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated","volume":"90","author":"Cepeda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000017294","article-title":"Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum","volume":"20","author":"Cepeda","year":"1998","journal-title":"Dev. Neurosci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","article-title":"Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/PL00007984","article-title":"A computational model of action selection in the basal ganglia. I. A new functional anatomy","volume":"84","author":"Gurney","year":"2001","journal-title":"Biol. Cybern."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1523\/JNEUROSCI.04-01-00111.1984","article-title":"DARPP-32, a dopamine- and adenosine 3\u2019:5\u2019-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization","volume":"4","author":"Ouimet","year":"1984","journal-title":"J. Neurosci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-8993(98)00724-0","article-title":"Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen","volume":"808","author":"Ouimet","year":"1998","journal-title":"Brain Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"53791","DOI":"10.18632\/oncotarget.17339","article-title":"The involvement of DARPP-32 in the pathophysiology of schizophrenia","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_157","first-page":"pyv134","article-title":"Involvement of the Striatal Medium Spiny Neurons of the Direct Pathway in the Motor Stimulant Effects of Phencyclidine","volume":"19","author":"DuPont","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.pnpbp.2007.04.013","article-title":"Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder","volume":"31","author":"Ishikawa","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.pnpbp.2011.03.016","article-title":"Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia","volume":"35","author":"Kunii","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1471-4159.2003.01851.x","article-title":"Opposite regulation by typical and atypical anti-psychotics of ERK1\/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum","volume":"86","author":"Pozzi","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1038\/npp.2011.144","article-title":"Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32","volume":"36","author":"Valjent","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00018-008-8150-y","article-title":"DARPP-32: Molecular integration of phosphorylation potential","volume":"65","author":"Li","year":"2008","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/301069a0","article-title":"A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions","volume":"301","author":"Walaas","year":"1983","journal-title":"Nature"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1016\/S0021-9258(17)39694-1","article-title":"Mammalian brain phosphoproteins as substrates for calcineurin","volume":"259","author":"King","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/343369a0","article-title":"Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices","volume":"343","author":"Halpain","year":"1990","journal-title":"Nature"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1523\/JNEUROSCI.20-15-05630.2000","article-title":"The Dopamine\/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway","volume":"20","author":"Paul","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1007\/s12035-017-0555-x","article-title":"Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP(61)","volume":"55","author":"Xu","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/gbb.12169","article-title":"Behavioral characterization of striatal-enriched protein tyrosine phosphatase (STEP) knockout mice","volume":"13","author":"Lotarski","year":"2014","journal-title":"Genes Brain Behav."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2018.00040","article-title":"Repeated Clozapine Increases the Level of Serotonin 5-HT(1A)R Heterodimerization with 5-HT(2A) or Dopamine D(2) Receptors in the Mouse Cortex","volume":"11","author":"Szlachta","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbrc.2010.09.110","article-title":"Dopamine D2 and 5-hydroxytryptamine 5-HT(2A) receptors assemble into functionally interacting heteromers","volume":"401","author":"Tarakanov","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbrc.2013.11.104","article-title":"Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes","volume":"443","author":"Narvaez","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bbamcr.2010.08.010","article-title":"Hetero-dimerization of serotonin 5-HT(2A) and dopamine D(2) receptors","volume":"1803","author":"Lukasiewicz","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"108236","DOI":"10.1016\/j.pharmthera.2022.108236","article-title":"Clozapine\u2019s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia","volume":"236","author":"Vellucci","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biochi.2019.01.009","article-title":"Dimers of serotonin receptors: Impact on ligand affinity and signaling","volume":"161","author":"Maroteaux","year":"2019","journal-title":"Biochimie"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2011.03.038","article-title":"Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its genetic variant 5-HT(2A)H425Y with dopamine D(2) receptor","volume":"659","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"36625","DOI":"10.1074\/jbc.M110.159954","article-title":"The dopamine D1-D2 receptor heteromer localizes in dynorphin\/enkephalin neurons: Increased high affinity state following amphetamine and in schizophrenia","volume":"285","author":"Perreault","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-6606-4-26","article-title":"Dopamine D1-D2 receptor heteromer signaling pathway in the brain: Emerging physiological relevance","volume":"4","author":"Hasbi","year":"2011","journal-title":"Mol. Brain"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.euroneuro.2008.12.006","article-title":"Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex","volume":"19","author":"Kruse","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.clinthera.2005.07.017","article-title":"Mechanism of action of antipsychotic drugs: From dopamine D(2) receptor antagonism to glutamate NMDA facilitation","volume":"27","author":"Laruelle","year":"2005","journal-title":"Clin. Ther."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrn4038","article-title":"A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition","volume":"16","author":"Jahanshahi","year":"2015","journal-title":"Nat. Reviews. Neurosci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nn.2723","article-title":"From reinforcement learning models to psychiatric and neurological disorders","volume":"14","author":"Maia","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.psc.2006.02.006","article-title":"Common and distinct neural correlates of obsessive-compulsive and related disorders","volume":"29","year":"2006","journal-title":"Psychiatr. Clin. N. Am."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tics.2011.11.003","article-title":"Obsessive-compulsive disorder: Beyond segregated cortico-striatal pathways","volume":"16","author":"Milad","year":"2012","journal-title":"Trends Cogn. Sci."},{"key":"ref_186","unstructured":"APA (2022). Diagnostic And Statistical Manual Of Mental Disorders: DSM-5-TR (Fifth Edition, Text Revision), American Psychiatric Association Publishing."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tics.2010.02.001","article-title":"Cortical and basal ganglia contributions to habit learning and automaticity","volume":"14","author":"Ashby","year":"2010","journal-title":"Trends Cogn. Sci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.neuron.2010.04.036","article-title":"Differential dynamics of activity changes in dorsolateral and dorsomedial striatal loops during learning","volume":"66","author":"Thorn","year":"2010","journal-title":"Neuron"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbr.2008.10.034","article-title":"The integrative function of the basal ganglia in instrumental conditioning","volume":"199","author":"Balleine","year":"2009","journal-title":"Behav. Brain Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nature04053","article-title":"Activity of striatal neurons reflects dynamic encoding and recoding of procedural memories","volume":"437","author":"Barnes","year":"2005","journal-title":"Nature"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.neuro.29.051605.112851","article-title":"Habits, rituals, and the evaluative brain","volume":"31","author":"Graybiel","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbr.2008.12.003","article-title":"Some highlights of research on the effects of caudate nucleus lesions over the past 200 years","volume":"199","author":"White","year":"2009","journal-title":"Behav. Brain Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0387-7604(03)90001-5","article-title":"Does an imbalance between the dorsal and ventral striatopallidal systems play a role in Tourette\u2019s syndrome? A neuronal circuit approach","volume":"25","author":"Groenewegen","year":"2003","journal-title":"Brain Dev."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pscychresns.2004.06.007","article-title":"Amygdala activity in obsessive-compulsive disorder with contamination fear: A study with oxygen-15 water positron emission tomography","volume":"132","author":"Veltman","year":"2004","journal-title":"Psychiatry Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archpsyc.62.8.922","article-title":"Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis","volume":"62","author":"Veltman","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.nicl.2014.03.011","article-title":"Amygdala hyperactivation during symptom provocation in obsessive-compulsive disorder and its modulation by distraction","volume":"4","author":"Simon","year":"2014","journal-title":"NeuroImage. Clin."},{"key":"ref_197","first-page":"728","article-title":"Fronto-striato-limbic hyperactivation in obsessive-compulsive disorder during individually tailored symptom provocation","volume":"47","author":"Simon","year":"2010","journal-title":"Psychophysiology"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1017\/S0033291715001026","article-title":"Emotion regulation before and after transcranial magnetic stimulation in obsessive compulsive disorder","volume":"45","author":"Trujillo","year":"2015","journal-title":"Psychol. Med."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/15622975.2011.559268","article-title":"Enhanced brain responsiveness during active emotional face processing in obsessive compulsive disorder","volume":"12","author":"Cardoner","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1192\/bjp.bp.112.123364","article-title":"Amygdala activation and symptom dimensions in obsessive-compulsive disorder","volume":"204","author":"Via","year":"2014","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/00004583-199612000-00016","article-title":"Comorbidity of juvenile obsessive-compulsive disorder with disruptive behavior disorders","volume":"35","author":"Geller","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1176\/appi.ajp.2013.13040574","article-title":"Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder","volume":"171","author":"Alonso","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1093\/cercor\/bhy306","article-title":"Schizophrenia Exhibits Bi-directional Brain-Wide Alterations in Cortico-Striato-Cerebellar Circuits","volume":"29","author":"Ji","year":"2019","journal-title":"Cereb. Cortex"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/schbul\/sbn145","article-title":"Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in schizophrenia","volume":"36","author":"Welsh","year":"2010","journal-title":"Schizophr. Bull."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1176\/appi.ajp.2012.12010056","article-title":"Thalamocortical dysconnectivity in schizophrenia","volume":"169","author":"Woodward","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/cercor\/bht165","article-title":"Characterizing thalamo-cortical disturbances in schizophrenia and bipolar illness","volume":"24","author":"Anticevic","year":"2014","journal-title":"Cereb. Cortex"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2017.04.002","article-title":"Resting-state functional connectivity between right anterior insula and right orbital frontal cortex correlate with insight level in obsessive-compulsive disorder","volume":"15","author":"Fan","year":"2017","journal-title":"NeuroImage. Clin."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtbi.2019.01.038","article-title":"Neural dynamics in co-morbid schizophrenia and OCD: A computational approach","volume":"473","author":"Silverstein","year":"2019","journal-title":"J. Theor. Biol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1523\/JNEUROSCI.4284-11.2012","article-title":"Striatal dopamine D2\/D3 receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans","volume":"32","author":"Ghahremani","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1002\/hbm.22895","article-title":"Interactions between glutamate, dopamine, and the neuronal signature of response inhibition in the human striatum","volume":"36","author":"Lorenz","year":"2015","journal-title":"Hum. Brain Mapp."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"de Bartolomeis, A., Vellucci, L., De Simone, G., Mazza, B., Barone, A., and Ciccarelli, M. (2023). Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics\u2019 Treatment of Schizophrenia. Cells, 12.","DOI":"10.3390\/cells12040574"},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Tomasetti, C., Iasevoli, F., Buonaguro, E.F., De Berardis, D., Fornaro, M., Fiengo, A.L., Martinotti, G., Orsolini, L., Valchera, A., and Di Giannantonio, M. (2017). Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010135"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00213-007-0855-3","article-title":"Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2\/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats","volume":"194","author":"Perreault","year":"2007","journal-title":"Psychopharmacology"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(89)90837-6","article-title":"Biphasic effect of D-2 agonist quinpirole on locomotion and movements","volume":"161","author":"Eilam","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/35041572","article-title":"Distinct functions of the two isoforms of dopamine D2 receptors","volume":"408","author":"Usiello","year":"2000","journal-title":"Nature"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00008877-199308000-00014","article-title":"Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole","volume":"4","author":"Szechtman","year":"1993","journal-title":"Behav. Pharmacol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02244757","article-title":"Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism","volume":"115","author":"Szechtman","year":"1994","journal-title":"Psychopharmacology"},{"key":"ref_218","first-page":"55","article-title":"Role of dopamine systems in obsessive-compulsive disorder (OCD): Implications from a novel psychostimulant-induced animal model","volume":"51","author":"Szechtman","year":"1999","journal-title":"Pol. J. Pharmacol."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Szechtman, H., Eckert, M.J., Tse, W.S., Boersma, J.T., Bonura, C.A., McClelland, J.Z., Culver, K.E., and Eilam, D. (2001). Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): Form and control. BMC Neurosci., 2.","DOI":"10.1186\/1471-2202-2-4"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neubiorev.2016.04.019","article-title":"Obsessive-compulsive disorder: Insights from animal models","volume":"76 Pt B","author":"Szechtman","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1073\/pnas.1814292116","article-title":"Basolateral amygdala input to the medial prefrontal cortex controls obsessive-compulsive disorder-like checking behavior","volume":"116","author":"Sun","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/ENEURO.0366-18.2019","article-title":"An Adenosine A(2A) Receptor Antagonist Improves Multiple Symptoms of Repeated Quinpirole-Induced Psychosis","volume":"6","author":"Asaoka","year":"2019","journal-title":"eNeuro"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fphar.2020.00057","article-title":"Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors","volume":"11","author":"Escobar","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuron.2016.12.005","article-title":"Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity","volume":"93","author":"Tejeda","year":"2017","journal-title":"Neuron"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0028-3908(02)00328-3","article-title":"Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow","volume":"44","author":"Koeltzow","year":"2003","journal-title":"Neuropharmacology"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/jnc.13209","article-title":"Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function","volume":"134","author":"Escobar","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1017\/S146114571200154X","article-title":"Evaluation of animal models of obsessive-compulsive disorder: Correlation with phasic dopamine neuron activity","volume":"16","author":"Sesia","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2008.06.101","article-title":"Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: Effects of pre-treatment with Ro 41-1049","volume":"592","author":"Culver","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnsys.2015.00171","article-title":"A Framework for Understanding the Emerging Role of Corticolimbic-Ventral Striatal Networks in OCD-Associated Repetitive Behaviors","volume":"9","author":"Wood","year":"2015","journal-title":"Front. Syst. Neurosci."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1073\/pnas.1701736114","article-title":"OCD candidate gene SLC1A1\/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior","volume":"114","author":"Zike","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.euroneuro.2013.05.012","article-title":"Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder","volume":"23","author":"Denys","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fnins.2013.00201","article-title":"Dopaminergic control of cognitive flexibility in humans and animals","volume":"7","author":"Klanker","year":"2013","journal-title":"Front. Neurosci."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/cap.2014.0048","article-title":"Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorder","volume":"25","author":"Cox","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41398-021-01700-4","article-title":"Immunological causes of obsessive-compulsive disorder: Is it time for the concept of an \u201cautoimmune OCD\u201d subtype?","volume":"12","author":"Endres","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/schbul\/23.1.63","article-title":"Perseveration in schizophrenia","volume":"23","author":"Crider","year":"1997","journal-title":"Schizophr. Bull."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fncom.2015.00031","article-title":"Improper activation of D1 and D2 receptors leads to excess noise in prefrontal cortex","volume":"9","author":"Avery","year":"2015","journal-title":"Front. Comput. Neurosci."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pscychresns.2005.07.002","article-title":"Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder","volume":"140","author":"Hesse","year":"2005","journal-title":"Psychiatry Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00702-007-0785-6","article-title":"Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity\u2014A [11C]DASB PET study","volume":"114","author":"Reimold","year":"2007","journal-title":"J. Neural Transm."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/npp.2008.35","article-title":"Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder","volume":"33","author":"Zitterl","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/pcn.12195","article-title":"Neurobiological model of obsessive-compulsive disorder: Evidence from recent neuropsychological and neuroimaging findings","volume":"68","author":"Nakao","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2011.07.032","article-title":"Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice","volume":"70","author":"Shanahan","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"ref_242","first-page":"533","article-title":"Autoregulation of serotonin neurons: Role in antidepressant drug action","volume":"51","author":"Blier","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pnpbp.2005.11.005","article-title":"Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder","volume":"30","author":"Blier","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/pr.119.017772","article-title":"The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap","volume":"72","author":"Szechtman","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1073\/pnas.1522754113","article-title":"Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids","volume":"113","author":"Geddes","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.neuron.2018.08.002","article-title":"Monitoring and Updating of Action Selection for Goal-Directed Behavior through the Striatal Direct and Indirect Pathways","volume":"99","author":"Nonomura","year":"2018","journal-title":"Neuron"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0006-8993(85)91435-0","article-title":"Pontine and mesencephalic substrates of self-stimulation","volume":"359","author":"Rompre","year":"1985","journal-title":"Brain Res."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"e06346","DOI":"10.7554\/eLife.06346","article-title":"Serotonergic neurons signal reward and punishment on multiple timescales","volume":"4","author":"Cohen","year":"2015","journal-title":"eLife"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/pcn.12942","article-title":"Transient and sustained effects of dopamine and serotonin signaling in motivation-related behavior","volume":"74","author":"Yagishita","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1021\/acschemneuro.9b00044","article-title":"Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models","volume":"10","author":"Shah","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_251","first-page":"76","article-title":"Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex","volume":"292","author":"Marek","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nn.4616","article-title":"Antipsychotic-induced Hdac2 transcription via NF-\u03baB leads to synaptic and cognitive side effects","volume":"20","author":"Ibi","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuropharm.2014.08.009","article-title":"Evaluation of 5-HT2A and mGlu2\/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment","volume":"86","author":"Muguruza","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson\u2019s disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(93)90250-L","article-title":"Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats","volume":"242","author":"Annies","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(92)90607-9","article-title":"Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis","volume":"142","author":"Whitton","year":"1992","journal-title":"Neurosci. Lett."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0014-2999(89)90378-6","article-title":"Glycine potentiates the NMDA-induced release of dopamine through a strychnine-insensitive site in the rat striatum","volume":"166","author":"Krebs","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1471-4159.1991.tb08224.x","article-title":"Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes","volume":"57","author":"Wang","year":"1991","journal-title":"J. Neurochem."},{"key":"ref_259","first-page":"722","article-title":"Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen","volume":"248","author":"Clow","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1570159X12666140324183406","article-title":"The glutamatergic aspects of schizophrenia molecular pathophysiology: Role of the postsynaptic density, and implications for treatment","volume":"12","author":"Iasevoli","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.mcn.2018.07.001","article-title":"Regulation of actin dynamics during structural plasticity of dendritic spines: Signaling messengers and actin-binding proteins","volume":"91","author":"Borovac","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12035-012-8293-6","article-title":"Calcium-dependent networks in dopamine-glutamate interaction: The role of postsynaptic scaffolding proteins","volume":"46","author":"Tomasetti","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/syn.890180306","article-title":"Haloperidol-induced morphological alterations are associated with changes in calcium\/calmodulin kinase II activity and glutamate immunoreactivity","volume":"18","author":"Meshul","year":"1994","journal-title":"Synapse"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0169-328X(01)00327-8","article-title":"Acute administration of antipsychotics modulates Homer striatal gene expression differentially","volume":"98","author":"Aloj","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"34391","DOI":"10.1038\/srep34391","article-title":"Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment","volume":"6","author":"Lum","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neubiorev.2019.08.019","article-title":"Translating preclinical findings in clinically relevant new antipsychotic targets: Focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia","volume":"107","author":"Avagliano","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"113160","DOI":"10.1016\/j.bbr.2021.113160","article-title":"Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis","volume":"404","author":"Barone","year":"2021","journal-title":"Behav. Brain Res."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1146\/annurev.biochem.76.060805.160029","article-title":"The postsynaptic architecture of excitatory synapses: A more quantitative view","volume":"76","author":"Sheng","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1523\/JNEUROSCI.4354-04.2005","article-title":"Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons","volume":"25","author":"Roussignol","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cell.2009.01.050","article-title":"The postsynaptic density proteins Homer and Shank form a polymeric network structure","volume":"137","author":"Hayashi","year":"2009","journal-title":"Cell"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn1517","article-title":"PDZ domain proteins of synapses","volume":"5","author":"Kim","year":"2004","journal-title":"Nat. Reviews. Neurosci."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.biochem.74.082803.133339","article-title":"Membrane-associated guanylate kinases regulate adhesion and plasticity at cell junctions","volume":"74","author":"Funke","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.neuron.2011.05.021","article-title":"Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses","volume":"70","author":"Gilman","year":"2011","journal-title":"Neuron"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/neuro.01.1.1.007.2007","article-title":"Select overexpression of homer1a in dorsal hippocampus impairs spatial working memory","volume":"1","author":"Celikel","year":"2007","journal-title":"Front. Neurosci."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"11586","DOI":"10.1523\/JNEUROSCI.3764-05.2005","article-title":"Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function","volume":"25","author":"Lominac","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.biopsych.2010.05.038","article-title":"Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression","volume":"68","author":"Rietschel","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pnpbp.2010.10.025","article-title":"The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes","volume":"35","author":"Tomasetti","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.brainresbull.2009.01.006","article-title":"Antipsychotic and antidepressant co-treatment: Effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders","volume":"79","author":"Tomasetti","year":"2009","journal-title":"Brain Res. Bull."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2007.08.022","article-title":"Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: Implication for glutamatergic postsynaptic density in antipsychotics action","volume":"150","author":"Tomasetti","year":"2007","journal-title":"Neuroscience"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/syn.20385","article-title":"Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain","volume":"61","author":"Panariello","year":"2007","journal-title":"Synapse"},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Bai, Y., Wang, H., and Li, C. (2022). SAPAP Scaffold Proteins: From Synaptic Function to Neuropsychiatric Disorders. Cells, 11.","DOI":"10.3390\/cells11233815"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/mp.2011.154","article-title":"De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia","volume":"17","author":"Kirov","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/mp.2012.85","article-title":"Genome-wide association study of obsessive-compulsive disorder","volume":"18","author":"Stewart","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s11689-016-9170-9","article-title":"Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variation","volume":"8","author":"Gazzellone","year":"2016","journal-title":"J. Neurodev. Disord."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13041-017-0324-9","article-title":"The DLGAP family: Neuronal expression, function and role in brain disorders","volume":"10","author":"Rasmussen","year":"2017","journal-title":"Mol. Brain"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/cne.20060","article-title":"Differential mRNA expression and protein localization of the SAP90\/PSD-95-associated proteins (SAPAPs) in the nervous system of the mouse","volume":"472","author":"Welch","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molbrainres.2004.03.014","article-title":"Distinct spatiotemporal expression of SAPAP transcripts in the developing rat brain: A novel dendritically localized mRNA","volume":"126","author":"Kindler","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1083\/jcb.136.3.669","article-title":"GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95\/SAP90 family of channel clustering molecules","volume":"136","author":"Kim","year":"1997","journal-title":"J. Cell Biol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0896-6273(00)80809-0","article-title":"Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor\/PSD-95\/GKAP complex and cortactin","volume":"23","author":"Naisbitt","year":"1999","journal-title":"Neuron"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"27463","DOI":"10.1074\/jbc.274.39.27463","article-title":"Synamon, a novel neuronal protein interacting with synapse-associated protein 90\/postsynaptic density-95-associated protein","volume":"274","author":"Yao","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/jnc.13232","article-title":"Shank synaptic scaffold proteins: Keys to understanding the pathogenesis of autism and other synaptic disorders","volume":"135","author":"Sala","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41537-022-00231-1","article-title":"Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain","volume":"8","author":"Fontana","year":"2022","journal-title":"Schizophrenia"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-neuro-062111-150442","article-title":"Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders","volume":"35","author":"Ting","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/35039075","article-title":"Postsynaptic organization and regulation of excitatory synapses","volume":"1","author":"Scannevin","year":"2000","journal-title":"Nat. Reviews. Neurosci."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.277.5331.1511","article-title":"Binding of neuroligins to PSD-95","volume":"277","author":"Irie","year":"1997","journal-title":"Science"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"13500","DOI":"10.1523\/JNEUROSCI.6439-10.2011","article-title":"Neurexin-neuroligin adhesions capture surface-diffusing AMPA receptors through PSD-95 scaffolds","volume":"31","author":"Mondin","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.neuron.2007.01.030","article-title":"The interaction between Stargazin and PSD-95 regulates AMPA receptor surface trafficking","volume":"53","author":"Bats","year":"2007","journal-title":"Neuron"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"106340","DOI":"10.1016\/j.phrs.2022.106340","article-title":"Shank postsynaptic scaffolding proteins in autism spectrum disorder: Mouse models and their dysfunctions in behaviors, synapses, and molecules","volume":"182","author":"Jung","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1128\/MCB.18.10.5838","article-title":"Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons","volume":"18","author":"Du","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/srep00484","article-title":"Synthesis of two SAPAP3 isoforms from a single mRNA is mediated via alternative translational initiation","volume":"2","author":"Chua","year":"2012","journal-title":"Sci. Rep."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrn3546","article-title":"Proteostasis in complex dendrites","volume":"14","author":"Hanus","year":"2013","journal-title":"Nat. Reviews. Neurosci."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuron.2012.02.036","article-title":"The local transcriptome in the synaptic neuropil revealed by deep sequencing and high-resolution imaging","volume":"74","author":"Cajigas","year":"2012","journal-title":"Neuron"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.biopsych.2013.01.008","article-title":"Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder","volume":"75","author":"Wan","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41398-023-02323-7","article-title":"The Sapap3 (\u2212\/\u2212) mouse reconsidered as a comorbid model expressing a spectrum of pathological repetitive behaviours","volume":"13","author":"Lamothe","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ajmg.b.30897","article-title":"Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study","volume":"150b","author":"Bienvenu","year":"2009","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/nn.3259","article-title":"GKAP orchestrates activity-dependent postsynaptic protein remodeling and homeostatic scaling","volume":"15","author":"Shin","year":"2012","journal-title":"Nat. Neurosci."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/j.celrep.2017.11.107","article-title":"Synaptic Targeting and Function of SAPAPs Mediated by Phosphorylation-Dependent Binding to PSD-95 MAGUKs","volume":"21","author":"Zhu","year":"2017","journal-title":"Cell Rep."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0006-3223(02)01491-9","article-title":"Selective regulation of presynaptic calcium\/calmodulin-dependent protein kinase II by psychotropic drugs","volume":"53","author":"Celano","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"20170023","DOI":"10.1098\/rstb.2017.0023","article-title":"Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour","volume":"373","author":"Wood","year":"2018","journal-title":"Philos. Trans. R. Soc. London. Ser. B Biol. Sci."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13041-020-00621-5","article-title":"Clozapine generates obsessive compulsive disorder-like behavior in mice","volume":"13","author":"Kang","year":"2020","journal-title":"Mol. Brain"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/YPG.0000000000000230","article-title":"New insights and perspectives on the genetics of obsessive-compulsive disorder","volume":"29","author":"Zai","year":"2019","journal-title":"Psychiatr. Genet."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"104743","DOI":"10.1016\/j.neubiorev.2022.104743","article-title":"Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review","volume":"139","author":"Rosson","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jad.2021.11.043","article-title":"Transcranial direct current stimulation improve symptoms and modulates cortical inhibition in obsessive-compulsive disorder: A TMS-EEG study","volume":"298","author":"Cheng","year":"2022","journal-title":"J. Affect. Disord."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"114530","DOI":"10.1016\/j.psychres.2022.114530","article-title":"A meta-analysis of the effects of non-invasive brain stimulation on obsessive-compulsive disorder","volume":"312","author":"Gao","year":"2022","journal-title":"Psychiatry Res."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clinph.2020.10.003","article-title":"Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines","volume":"132","author":"Rossi","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.clinph.2017.06.001","article-title":"Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines","volume":"128","author":"Antal","year":"2017","journal-title":"Clin. Neurophysiol."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"110672","DOI":"10.1016\/j.pnpbp.2022.110672","article-title":"Transcranial direct current stimulation for bipolar depression: Systematic reviews of clinical evidence and biological underpinnings","volume":"121","author":"Toscano","year":"2023","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"866245","DOI":"10.3389\/fnins.2022.866245","article-title":"Transcranial Magnetic Stimulation and Neocortical Neurons: The Micro-Macro Connection","volume":"16","author":"Tian","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/j.1460-9568.2006.04676.x","article-title":"Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex","volume":"23","author":"Nitsche","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/npp.2015.270","article-title":"Chronic Enhancement of Serotonin Facilitates Excitatory Transcranial Direct Current Stimulation-Induced Neuroplasticity","volume":"41","author":"Kuo","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"16464","DOI":"10.1523\/JNEUROSCI.1542-11.2011","article-title":"Increase in cortical pyramidal cell excitability accompanies depression-like behavior in mice: A transcranial magnetic stimulation study","volume":"31","author":"Sun","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"136977","DOI":"10.1016\/j.neulet.2022.136977","article-title":"The effect of low-frequency rTMS on auditory hallucinations, EEG source localization and functional connectivity in schizophrenia","volume":"794","author":"Gornerova","year":"2023","journal-title":"Neurosci. Lett."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1176\/appi.ajp.2012.11071091","article-title":"Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia","volume":"169","author":"Brunelin","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpsychires.2022.09.011","article-title":"Effects of bilateral, bipolar-nonbalanced, frontal transcranial Direct Current Stimulation (tDCS) on negative symptoms and neurocognition in a sample of patients living with schizophrenia: Results of a randomized double-blind sham-controlled trial","volume":"155","author":"Lisoni","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"135912","DOI":"10.1016\/j.neulet.2021.135912","article-title":"Left prefrontal transcranial direct-current stimulation reduces symptom-severity and acutely enhances working memory in schizophrenia","volume":"755","author":"Meiron","year":"2021","journal-title":"Neurosci. Lett."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/13554794.2015.1045522","article-title":"Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder","volume":"22","author":"Brunoni","year":"2016","journal-title":"Neurocase"},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41386-020-00928-w","article-title":"Efficacy and safety of transcranial direct current stimulation as an add-on treatment for obsessive-compulsive disorder: A randomized, sham-controlled trial","volume":"46","author":"Silva","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jpsychires.2020.10.030","article-title":"Functional connectivity changes and symptoms improvement after personalized, double-daily dosing, repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: A pilot study","volume":"136","author":"Mantovani","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.schres.2003.08.013","article-title":"Comparative neuropsychological function in obsessive-compulsive disorder and schizophrenia with and without obsessive-compulsive symptoms","volume":"69","author":"Whitney","year":"2004","journal-title":"Schizophr. Res."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/WNF.0000000000000248","article-title":"Early Onset Schizophrenia Associated With Obsessive-Compulsive Disorder: Clinical Features and Correlates","volume":"40","author":"Baytunca","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"e1224","DOI":"10.1038\/tp.2017.189","article-title":"The neural correlates of obsessive-compulsive disorder: A multimodal perspective","volume":"7","author":"Moreira","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/14728222.2014.981529","article-title":"Dopamine heteroreceptor complexes as therapeutic targets in Parkinson\u2019s disease","volume":"19","author":"Fuxe","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.neuropharm.2012.01.010","article-title":"Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades","volume":"62","author":"Delille","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41398-022-02253-w","article-title":"Glutamatergic dysfunction in Schizophrenia","volume":"12","author":"Kruse","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"104596","DOI":"10.1016\/j.neubiorev.2022.104596","article-title":"The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular \u201cLego\u201d in the pathophysiology of psychiatric disorders. A systematic review and translational insight","volume":"136","author":"Barone","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neubiorev.2020.07.038","article-title":"The role of norepinephrine in the pathophysiology of schizophrenia","volume":"118","author":"Andreassen","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2015.07.017","article-title":"The GABA system in schizophrenia: Cells, molecules and microcircuitry","volume":"167","author":"Benes","year":"2015","journal-title":"Schizophr. Res."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"26548","DOI":"10.4088\/JCP.MS19053BR3C","article-title":"Current Treatment Options and Emerging Agents for Schizophrenia","volume":"81","author":"Correll","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0893-133X(98)00121-3","article-title":"Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia","volume":"21","author":"Dalack","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","article-title":"Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders: A Mendelian Randomization Study","volume":"79","author":"Williams","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1007\/s12035-022-02976-3","article-title":"Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: A Systematic Review","volume":"59","author":"Barone","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/7854_2020_210","article-title":"Inflammation, Obsessive-Compulsive Disorder, and Related Disorders","volume":"49","author":"Meyer","year":"2021","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41562-023-01530-y","article-title":"A meta-analysis of genetic effects associated with neurodevelopmental disorders and co-occurring conditions","volume":"7","author":"Gidziela","year":"2023","journal-title":"Nat. Hum. Behav."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/8\/1220\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:26:31Z","timestamp":1760127991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/8\/1220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,5]]},"references-count":343,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["biom13081220"],"URL":"https:\/\/doi.org\/10.3390\/biom13081220","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,5]]}}}